Literature DB >> 31310926

Elevated CHI3L1 and OPN levels in patients with anti-N-methyl-d-aspartate receptor encephalitis.

Jing Zhao1, Cancan Wang1, Yuanxing Zhang1, Ruihua Sun1, Huayuan Wang1, Gai Li1, Jiewen Zhang2.   

Abstract

Chitinase-3-like 1 (CHI3L1) and osteopontin (OPN) are known biomarkers of neuroinflammation. Herein, we explored the relationship between these inflammatory markers with the disease severity and prognosis in anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis. We recruited 36 anti-NMDAR encephalitis patients and 20 controls. Compared to the levels in the controls, the cerebrospinal fluid (CSF) and serum levels of CHI3L1 and OPN were significantly increased in patients with anti-NMDAR encephalitis, and the CSF levels were found to be correlated with the initial and 6-month follow-up modified Rankin Scale (mRS) scores and abnormal brain MRI (suggestive of encephalitis). In addition, the CSF levels of CHI3L1 were associated with age, the CSF white blood cell (WBC) count and the CSF/serum albumin index (CSF-AI). CHI3L1 and OPN might serve as promising biomarkers for anti-NMDAR encephalitis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-NMDAR encephalitis; Autoimmune encephalitis; Chitinase-3-like 1; Osteopontin

Year:  2019        PMID: 31310926     DOI: 10.1016/j.jneuroim.2019.577005

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

Review 1.  Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.

Authors:  Nicolás Lundahl Ciano-Petersen; Pablo Cabezudo-García; Sergio Muñiz-Castrillo; Jérôme Honnorat; Pedro Jesús Serrano-Castro; Begoña Oliver-Martos
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

Review 2.  Advances in Potential Cerebrospinal Fluid Biomarkers for Autoimmune Encephalitis: A Review.

Authors:  Shuyu Zhang; Chengyuan Mao; Xinwei Li; Wang Miao; Junfang Teng
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.